Cognition, learning, brain function Mental and Behavioural Disorders Cognition, learning, brain function
Conditions
Interventions
Current Interventions as of 17/03/2017:
Participants are allocated to the intervention group or the control group.
Intervention group: Participants take part in high-i
Sponsors
University of Jyväskylä
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 17/03/2017: 1. Aged 15-19 years of age 2. Attending high school and vocational schools Previous inclusion criteria: 1. Aged 15-17 years of age 2. Attending high school and vocational schools
Exclusion criteria
Exclusion criteria: 1. Heart disease 2. Untreated or poorly controlled type 1 diabetes 3. Musculoskeletal disease or trauma 4. Severe depression or anxiety
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 17/03/2017: 1. Attention, working memory, associative learning, processing speed and executive function is measured using the computerized CogState battery at the baseline and at the 3 months 2. Brain functions by magnetoencephalography (MEG) in a subsample of participants taking part in sub study investigating the effects of acute high intensity interval training on cognition and brain functioning. Previous primary outcome measures: 1. Attention, working memory, associative learning, processing speed and executive function is measured using the computerized CogState battery at the baseline and at the 3 months 2. Reading and arithmetic skills are measured using pseudo word reading and KTLT tests, respectively, at the baseline and at the 3 months 3. Brain functions by magnetoencephalography (MEG) at baseline and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 17/03/2017: 1. Cardiorespiratory fitness is measured using maximal cycle ergometer test with respiratory gas analyses at baseline and 3 months 2. Physical activity is measured using PA-3D accelerometer, the Youth Physical Activity Questionnaire and the Youth Sedentary Behaviour questionnaire at baseline and 3-months 3. Sleep length and quality is measured using the Epworth sleepiness scale and Basic Nordic Sleep Questionnaire at baseline and 3 months 4. Arterial stiffness is measured using an Arteriograph at baseline and 3 months 5. Motivation is measured using a questionnaire developed by Professor Niemivirta in the 2002 study "Motivation and performance in context: The influence of goal orientations and instructional setting on situational appraisal and task performance" at baseline and 3 months 6. Self-efficacy is measured using a questionnaire developed by Professor Niemivirta in the 2002 study "Motivation and performance in context: The influence of goal orientations and instructional setting on situational appraisal and task performance" at baseline and 3 months 7. Depression is measured using the 21 item Beck Depression Scale at baseline and 3 months Previous secondary outcome measures: 1. Cardiorespiratory fitness is measured using maximal cycle ergometer test with respiratory gas analyses at baseline and 3 months 2. Physical activity is measured using PA-3D accelerometer, the Youth Physical Activity Questionnaire and the Youth Sedentary Behaviour questionnaire at baseline and 3-months 3. Sleep length and quality is measured using the Epworth sleepiness scale and Basic Nordic Sleep Questionnaire at baseline and 3 months 4. Arterial stiffness is measured using an Arteriograph at baseline and 3 months 5. Adiposity | — |
Countries
Finland
Outcome results
None listed